Trial Type: Other Hematopoietic

BH-P-LUMINA-3
A Multicenter, Open-label, Phase IIb Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (LUMINA 2)
Protocol Status: OPEN TO ACCRUAL
Trial Type: Other Hematology, Other Hematopoietic
Contact: Hsu, Andrew
ahsu2@BrownHealth.org